Home543322 • BOM
add
Alivus Life Sciences Ltd
Nakaraang pagsara
₹1,102.80
Sakop ng araw
₹1,101.00 - ₹1,124.00
Sakop ng taon
₹827.10 - ₹1,259.75
Market cap
136.72B INR
Average na Volume
3.94K
P/E ratio
28.26
Dividend yield
-
Primary exchange
NSE
Mga balita tungkol sa merkado
CNN
3 araw ang nakalipas
Dow sinks 800 points as bond market starts to freak out over Trump’s tax bill
0.61%
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 6.60B | 22.93% |
Gastos sa pagpapatakbo | 1.84B | 40.04% |
Net na kita | 1.42B | 44.86% |
Net profit margin | 21.51 | 17.86% |
Kita sa bawat share | 11.55 | 44.92% |
EBITDA | 2.08B | 48.36% |
Aktuwal na % ng binabayarang buwis | 25.84% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 5.49B | 82.09% |
Kabuuang asset | 34.11B | 19.68% |
Kabuuang sagutin | 5.94B | 14.67% |
Kabuuang equity | 28.17B | — |
Natitirang share | 122.62M | — |
Presyo para makapag-book | 4.80 | — |
Return on assets | — | — |
Return on capital | 17.74% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 1.42B | 44.86% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
CEO
Itinatag
2011
Website
Mga Empleyado
2,014
